These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
271 related items for PubMed ID: 30508730
1. Synthesis of novel gallium-68 labeled rhodamine: A potential PET myocardial perfusion agent. Jammaz IA, Al-Otaibi B, Al-Hokbani N, Okarvi SM. Appl Radiat Isot; 2019 Feb; 144():29-33. PubMed ID: 30508730 [Abstract] [Full Text] [Related]
2. Development of new copper-64 labeled rhodamine: a potential PET myocardial perfusion imaging agent. AlHokbany N, AlJammaz I, AlOtaibi B, AlMalki Y, AlJammaz B, Okarvi SM. EJNMMI Radiopharm Chem; 2022 Jul 23; 7(1):19. PubMed ID: 35870027 [Abstract] [Full Text] [Related]
3. Novel synthesis and initial preclinical evaluation of (18)F-[FDG] labeled rhodamine: a potential PET myocardial perfusion imaging agent. AlJammaz I, Al-Otaibi B, AlHindas H, Okarvi SM. Nucl Med Biol; 2015 Oct 23; 42(10):804-8. PubMed ID: 26160144 [Abstract] [Full Text] [Related]
4. 68Ga labeled fatty acids for cardiac metabolic imaging: Influence of different bifunctional chelators. Jain A, Mathur A, Pandey U, Sarma HD, Dash A. Bioorg Med Chem Lett; 2016 Dec 01; 26(23):5785-5791. PubMed ID: 27793567 [Abstract] [Full Text] [Related]
5. Evaluating Ga-68 Peptide Conjugates for Targeting VPAC Receptors: Stability and Pharmacokinetics. Kumar P, Tripathi SK, Chen CP, Wickstrom E, Thakur ML. Mol Imaging Biol; 2019 Feb 01; 21(1):130-139. PubMed ID: 29802552 [Abstract] [Full Text] [Related]
6. Preparation, Characterization, and Radiolabeling of [68Ga]Ga-NODAGA-Pamidronic Acid: A Potential PET Bone Imaging Agent. Ashhar Z, Yusof NA, Ahmad Saad FF, Mohd Nor SM, Mohammad F, Bahrin Wan Kamal WH, Hassan MH, Ahmad Hassali H, Al-Lohedan HA. Molecules; 2020 Jun 09; 25(11):. PubMed ID: 32526838 [Abstract] [Full Text] [Related]
7. Development and Validation of an Analytical HPLC Method to Assess Chemical and Radiochemical Purity of [68Ga]Ga-NODAGA-Exendin-4 Produced by a Fully Automated Method. Migliari S, Sammartano A, Boss M, Gotthardt M, Scarlattei M, Baldari G, Silva C, Bonadonna RC, Ruffini L. Molecules; 2022 Jan 15; 27(2):. PubMed ID: 35056858 [Abstract] [Full Text] [Related]
8. Radiolabeling and Preliminary Evaluation of Ga-68 Labeled NODAGA-Ubiquicidin Fragments for Prospective Infection Imaging. Bhatt J, Mukherjee A, Korde A, Kumar M, Sarma HD, Dash A. Mol Imaging Biol; 2017 Feb 15; 19(1):59-67. PubMed ID: 27406090 [Abstract] [Full Text] [Related]
9. Synthesis and in vivo evaluation of gallium-68-labeled glycine and hippurate conjugates for positron emission tomography renography. Pathuri G, Hedrick AF, January SE, Galbraith WK, Awasthi V, Arnold CD, Cowley BD, Gali H. J Labelled Comp Radiopharm; 2015 Jan 15; 58(1):14-9. PubMed ID: 25545452 [Abstract] [Full Text] [Related]
10. Toward realization of 'mix-and-use' approach in ⁶⁸Ga radiopharmacy: preparation, evaluation and preliminary clinical utilization of ⁶⁸Ga-labeled NODAGA-coupled RGD peptide derivative. Chakraborty S, Chakravarty R, Vatsa R, Bhusari P, Sarma HD, Shukla J, Mittal BR, Dash A. Nucl Med Biol; 2016 Jan 15; 43(1):116-123. PubMed ID: 26527030 [Abstract] [Full Text] [Related]
11. Comparative Evaluation of Using NOTA and DOTA Derivatives as Bifunctional Chelating Agents in the Preparation of 68Ga-Labeled Porphyrin: Impact on Pharmacokinetics and Tumor Uptake in a Mouse Model. Guleria M, Das T, Amirdhanayagam J, Sarma HD, Dash A. Cancer Biother Radiopharm; 2018 Feb 15; 33(1):8-16. PubMed ID: 29373046 [Abstract] [Full Text] [Related]
12. (64)Cu- and (68)Ga-Based PET Imaging of Folate Receptor-Positive Tumors: Development and Evaluation of an Albumin-Binding NODAGA-Folate. Farkas R, Siwowska K, Ametamey SM, Schibli R, van der Meulen NP, Müller C. Mol Pharm; 2016 Jun 06; 13(6):1979-87. PubMed ID: 27145400 [Abstract] [Full Text] [Related]
13. Molecular Design of HER3-Targeting Affibody Molecules: Influence of Chelator and Presence of HEHEHE-Tag on Biodistribution of 68Ga-Labeled Tracers. Dahlsson Leitao C, Rinne SS, Mitran B, Vorobyeva A, Andersson KG, Tolmachev V, Ståhl S, Löfblom J, Orlova A. Int J Mol Sci; 2019 Mar 02; 20(5):. PubMed ID: 30832342 [Abstract] [Full Text] [Related]
14. Imaging of αvβ3 integrin expression in experimental myocardial ischemia with [68Ga]NODAGA-RGD positron emission tomography. Grönman M, Tarkia M, Kiviniemi T, Halonen P, Kuivanen A, Savunen T, Tolvanen T, Teuho J, Käkelä M, Metsälä O, Pietilä M, Saukko P, Ylä-Herttuala S, Knuuti J, Roivainen A, Saraste A. J Transl Med; 2017 Jun 19; 15(1):144. PubMed ID: 28629432 [Abstract] [Full Text] [Related]
15. Radiochemical synthesis and preclinical evaluation of 68Ga-labeled NODAGA-hydroxypropyl-beta-cyclodextrin (68Ga-NODAGA-HPBCD). Hajdu I, Angyal J, Szikra D, Kertész I, Malanga M, Fenyvesi É, Szente L, Vecsernyés M, Bácskay I, Váradi J, Fehér P, Ujhelyi Z, Vasvári G, Rusznyák Á, Trencsényi G, Fenyvesi F. Eur J Pharm Sci; 2019 Feb 01; 128():202-208. PubMed ID: 30521943 [Abstract] [Full Text] [Related]
18. Synthesis of fluorine-18 labeled rhodamine B: A potential PET myocardial perfusion imaging agent. Heinrich TK, Gottumukkala V, Snay E, Dunning P, Fahey FH, Ted Treves S, Packard AB. Appl Radiat Isot; 2010 Jan 01; 68(1):96-100. PubMed ID: 19783150 [Abstract] [Full Text] [Related]
19. 68Ga-labeling and in vivo evaluation of a uPAR binding DOTA- and NODAGA-conjugated peptide for PET imaging of invasive cancers. Persson M, Madsen J, Østergaard S, Ploug M, Kjaer A. Nucl Med Biol; 2012 May 01; 39(4):560-9. PubMed ID: 22172391 [Abstract] [Full Text] [Related]
20. In vivo preclinical evaluation of the new 68Ga-labeled beta-cyclodextrin in prostaglandin E2 (PGE2) positive tumor model using positron emission tomography. Trencsényi G, Kis A, Szabó JP, Ráti Á, Csige K, Fenyvesi É, Szente L, Malanga M, Méhes G, Emri M, Kertész I, Vecsernyés M, Fenyvesi F, Hajdu I. Int J Pharm; 2020 Feb 25; 576():118954. PubMed ID: 31935470 [Abstract] [Full Text] [Related] Page: [Next] [New Search]